scorecardresearch
Add as a preferred source on Google
Saturday, November 1, 2025
TopicDCGI

Topic: DCGI

Drug regulator DCGI extends shelf life of Covishield vaccine from 6 to 9 months

In a letter to the Serum Institute, Drugs Controller General of India Somani said the institute is permitted to apply the shelf life of 9 months to unlabeled vials available on hand.

‘No uniform test for cancer-causing substances in J&J baby products’ — drug regulator summoned

Child rights body issues summons over lack of standard testing methods to screen for presence of formaldehyde and asbestos in Johnson & Johnson’s baby shampoo and talcum powder.

Zee News on vaccine approval, Times Now on ‘green shoots’ in Indian economy

A quick take on what prime time TV news talked about.

Serum expects govt to sign pricing deal for Covishield within days

Officials have 'indicated orally' that first 100mn vaccines will be purchased at Rs 200 & a deal should be inked 'in next one or two days', according to Serum CEO Adar Poonawalla.

Strict follow-up, informed consent from recipients — conditions set for cleared Covid vaccines

India has given conditional emergency-use licence to two Covid vaccines — the Oxford-AstraZeneca candidate Covishield, and Bharat Biotech’s Covaxin.

Dr Reddy’s gets drug controller’s nod to conduct human clinical trial for Russian vaccine

Earlier in September 2020, Dr.Reddy's and Russian Direct Investment Fund entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.

Expert panel asks Dr Reddy’s to reapply for phase 2, 3 trials of Russian Covid vaccine

According to the CDSCO panel, the pharma company has to conduct both phase 2 and 3 clinical trials and cannot directly hold phase 3 trial for the vaccine in India, a source said.

DCGI approves commercial launch of low cost Covid-19 test ‘Feluda’

The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test achieves accuracy levels of RT-PCR tests with quicker turnaround time & less expensive equipment.

Govt approves manufacture of 471 cocktail drugs related to vitamins, minerals, micronutrients

The safety of these fixed drug combinations will be monitored regularly and any failure on the manufacturers' part to submit a periodic safety update will be deemed illegal.

Task force decides against including Itolizumab in clinical management protocols for Covid

Itolizumab was approved for 'restricted emergency use' in the treatment of coronavirus by the Drugs Controller General of India (DCGI) recently.

On Camera

Shah Rukh Khan’s India is about love, not hate. Chak De! India to My Name Is Khan

This year, Jawan and The Kerala Story both won National Awards. The irony was impossible to miss. One critiqued the system, the other endorsed its narratives. The dichotomy says more about India’s cultural schizophrenia than any film review ever could.

Consumer Price Index gets up to date. Airfare, OTT plans, e-commerce prices in new basket—MoSPI secy

New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.

Joint production, closer ties, emerging tech: The foundation of new defence pact between India & US

The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.